Flow cytometric aberrancies in plasma cell myeloma and MGUS – correlation with laboratory parameters
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 23, 2018 Category: Molecular Biology Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 23, 2018 Category: Molecular Biology Source Type: research

Usefulness of the CLLflow score
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Authors: MarcSorigue , MireiaFranch ‐Sarto , EdurneSarrate , JordiJunca Source Type: research

B cell ‐specific protein FCRLA is expressed by plasmacytoid dendritic cells in humans
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Authors: EvdokiyaReshetnikova , SergeyGuselnikov , OlgaVolkova , KonstantinBaranov , AlexanderTaranin , LudmilaMechetina Source Type: research

Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Authors: Prashant R.Tembhare , SitaramGhogale , WilmaTauro , YajamanamBadrinath , NileshDeshpande , ShwetaKedia , KeziahCherian , Nikhil V.Patkar , GauravChatterjee , SumeetGujral , Papagudi G.Subramanian Source Type: research

B cell ‐specific protein FCRLA is expressed by plasmacytoid dendritic cells in humans
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Source Type: research

Usefulness of the CLLflow score
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Source Type: research

Evaluation of CD229 as a new alternative plasma cell gating marker in the flow cytometric immunophenotyping of monoclonal gammopathies
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 19, 2018 Category: Molecular Biology Source Type: research

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
Cytometry Part B: Clinical Cytometry, Page 121-128, September 2018. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Authors: Andy C. Rawstron, Karl ‐Anton Kreuzer, Asha Soosapilla, Martin Spacek, Olga Stehlikova, Peter Gambell, Neil McIver‐Brown, Neus Villamor, Katherina Psarra, Maria Arroz, Raffaella Milani, Javier de la Serna, M. Teresa Cedena, Ozren Jaksic, Source Type: research

Leptomeningeal myelomatosis diagnosed by an eight ‐color single tube in dried formulation. A case report
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Authors: GiovanniCarulli , FrancescoCaracciolo , PaolaSammuri , CristianaDomenichini , AngelaTarasco , MartinaRousseau , VirginiaOttaviano , MarioPetrini Source Type: research

Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5 ‐positive B‐cell neoplasms
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Authors: DavidStarostka , EvaKriegova , MilosKudelka , PeterMikula , SarkaZehnalova , MartinRadvansky , TomasPapajik , DavidKolacek , KaterinaChasakova , HanaTalianova Source Type: research